Inventor · disambiguated record
Katherine Eleanor Crosby
Also filed as: CROSBY KATHERINE · CROSBY KATHERINE ELEANOR
8 granted patents·15 pending applications·48 citations·filing 2002–2021
83Inventor score
Files withCELL SIGNALING TECHNOLOGY INC16RIMKUNAS VICTORIA MCGUINNESS2CELL SIGNALLING TECHNOLOGY INC1GU TING LEI1HAACK HERBERT1
Top patents by PatentIndex Score
23 records- 0186US7183385B2Phospho-specific antibodies to Flt3 and uses thereofCELL SIGNALING TECHNOLOGY INC·Filed 2003·Granted Feb 27, 2007·40 cites·15 claims
- 0285US10551383B2Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Feb 4, 2020·2 cites·5 claims
- 0374US2022003771A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 0472US2020363417A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 0570US8466160B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alphaRIKOVA KLARISA·Filed 2010·Granted Jun 18, 2013·1 cites·10 claims
- 0669US7932044B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-αCELL SIGNALING TECHNOLOGY INC·Filed 2005·Granted Apr 26, 2011·2 cites·13 claims
- 0769US2022267854A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 0868US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 0965US9364477B2Mutant ROS expression in human cancerGU TING-LEI·Filed 2010·Granted Jun 14, 2016·1 cites·24 claims
- 1064US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 1160US2016193208A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alphaCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 1259US9539254B2Mutant ROS expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Jan 10, 2017·0 cites·8 claims
- 1359US2013266965A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHACELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 1455US2017275706A1Alk and ros kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 1555US2015056193A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 1654US2012101108A1Anaplastic Lymphoma Kinase In Kidney CancerHAACK HERBERT·Filed 2011·Application pending·0 cites
- 1751US7105642B2Monoclonal antibodies specific for phosphorylated estrogen receptor alpha (Ser118) and uses thereofCELL SIGNALLING TECHNOLOGY INC·Filed 2002·Granted Sep 12, 2006·2 cites·4 claims
- 1848US2017071941A1Mutant ros expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 1947US2012208824A1ROS Kinase in Lung CancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
- 2044US2013288240A1Alk and ros kinase in cancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
- 2141US2003190689A1Molecular profiling of disease and therapeutic response using phospho-specific antibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2003·Application pending·0 cites
- 2240US2004106141A1Methods and materials for examining pathways associated with glioblastoma progressionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2340US2003190688A1Methods for detecting BCR-ABL signaling activity in tissues using phospho-specific antibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine Eleanor Crosby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →